---
title: "Better dividend king to buy right now: AbbVie or Johnson & Johnson?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293843937.md"
description: "Both have very promising futures."
datetime: "2026-07-26T10:58:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293843937.md)
  - [en](https://longbridge.com/en/news/293843937.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293843937.md)
generator: "portal-rs"
---

# Better dividend king to buy right now: AbbVie or Johnson & Johnson?

Both have very promising futures.

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [Is AbbVie (ABBV) Fairly Valued As New Lung Cancer Data Impresses?](https://longbridge.com/en/news/296816441.md)
- [Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?](https://longbridge.com/en/news/296709148.md)
- [Mega IPOs Could be Coming: Here’s How They Might Impact Dividends](https://longbridge.com/en/news/296815476.md)
- [Johnson & Johnson $JNJ Position Reduced by Oppenheimer Asset Management Inc.](https://longbridge.com/en/news/296697035.md)
- [AllianceBernstein Global High Income Fund declares $0.0655 dividend](https://longbridge.com/en/news/296913007.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**